Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.22.2.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Assets    
Cash and cash equivalents $ 272,808 $ 226,204
Equity method investments 1,921,515 1,759,651
Receivables 1,614,000  
Receivables held-for-sale 16,885 22,214
Real estate 358,346 356,088
Investments 10,600 17,697
Securitization assets 177,927 210,354
Other assets 125,204 132,165
Total Assets 4,497,892 4,148,311
Liabilities:    
Accounts payable, accrued expenses and other 118,655 88,866
Credit facilities 100,626 100,473
Commercial paper notes 99,873 50,094
Senior unsecured notes 1,777,343 1,762,763
Convertible notes 341,900 149,731
Total Liabilities 2,846,866 2,581,796
Stockholders’ Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding 0 0
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 88,838,705 and 85,326,781 shares issued and outstanding, respectively 888 853
Additional paid in capital 1,861,466 1,727,667
Accumulated deficit (231,417) (193,706)
Accumulated other comprehensive income (loss) (14,769) 9,904
Non-controlling interest 34,858 21,797
Total Stockholders’ Equity 1,651,026 1,566,515
Total Liabilities and Stockholders’ Equity 4,497,892 4,148,311
Non-recourse    
Liabilities:    
Non-recourse debt (secured by assets of $606 million and $592 million, respectively) 408,469 429,869
Commercial receivables    
Assets    
Receivables 1,511,261 1,298,529
Government receivables    
Assets    
Receivables $ 103,346 $ 125,409